Nature Communications (Jun 2022)

Ru(II) photocages enable precise control over enzyme activity with red light

  • Dmytro Havrylyuk,
  • Austin C. Hachey,
  • Alexander Fenton,
  • David K. Heidary,
  • Edith C. Glazer

DOI
https://doi.org/10.1038/s41467-022-31269-5
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 10

Abstract

Read online

The cytochrome P450 enzyme CYP1B1 is overexpressed in a variety of tumors, and is correlated with poor treatment outcomes; thus, it is desirable to develop CYP1B1 inhibitors to restore chemotherapy efficacy. Here the authors describe the creation of light-triggered CYP1B1 inhibitors as “prodrugs”, and achieve >6000-fold improvement in potency upon activation with low-energy (660 nm) light.